MAPK3 and ocular melanoma: However, the expression of the phosphorylated P-ERK1/2 differed significantly between the groups: it was significantly higher in the OM group compared to the control group (p < 0.01) and was highly inhibited after treatment with imperatorin or P2X4 shRNA (p < 0.01).